{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:26:15Z","timestamp":1788323175517,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jnutbio.2024.109717","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T16:16:18Z","timestamp":1722701778000},"page":"109717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hepatic miR-363 promotes nonalcoholic fatty liver disease by suppressing INSIG1"],"prefix":"10.1016","volume":"134","author":[{"given":"Lechen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2024.109717_bib0001","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0002","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0003","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0004","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0005","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gutjnl-2016-312869","article-title":"miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression","volume":"67","author":"Hanin","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0006","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0007","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/hep.32381","article-title":"Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis","volume":"76","author":"Jiang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2012.06.014","article-title":"Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis","volume":"16","author":"Liu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-13-86","article-title":"MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1","volume":"13","author":"Ji","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat Rev Gastro Hepat"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0013","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.redox.2015.04.009","article-title":"Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells","volume":"5","author":"Banerjee","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0015","article-title":"Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin","volume":"8","author":"Ginwala","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-5-76","article-title":"Apigenin inhibits pancreatic cancer cell proliferation through G2\/M cell cycle arrest","volume":"5","author":"Ujiki","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2017.10.041","article-title":"Apigenin: a dietary flavonoid with diverse anticancer properties","volume":"413","author":"Madunic","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0018","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2015-311314","article-title":"Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation","volume":"65","author":"Blaya","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0019","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jcmm.12733","article-title":"miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21","volume":"20","author":"Xiao","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0020","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3892\/ijmm.2015.2092","article-title":"MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis","volume":"35","author":"Katsura","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","article-title":"Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake","volume":"3","author":"Gong","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0022","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jhep.2020.07.048","article-title":"miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder","volume":"74","author":"Fan","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0023","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1136\/gutjnl-2015-310044","article-title":"Emerging role of miR-21 in non-alcoholic fatty liver disease","volume":"65","author":"Benhamouche-Trouillet","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0024","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0025","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","article-title":"Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma","volume":"19","author":"Hou","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0027","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0028","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0029","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI20978","article-title":"Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis","volume":"113","author":"Engelking","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jdi.13695","article-title":"Micro ribonucleic acid-363 regulates the phosphatidylinositol 3-kinase\/threonine protein kinase axis by targeting NOTCH1 and forkhead box C2, leading to hepatic glucose and lipids metabolism disorder in type 2 diabetes mellitus","volume":"13","author":"Peng","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154839","article-title":"miR-363-3p\/PTEN is involved in the regulation of lipid metabolism by genistein in HepG2 cells via ERbeta","volume":"115","author":"Qin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155660","article-title":"miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis","volume":"146","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0033","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.32562","article-title":"Endoplasmic reticulum stress in liver diseases","volume":"77","author":"Ajoolabady","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0034","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0035","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1080\/10408398.2021.1917508","article-title":"Absorption, metabolism and bioavailability of flavonoids: a review","volume":"62","author":"Chen","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0036","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.foodchem.2013.05.019","article-title":"Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats","volume":"141","author":"Zhang","year":"2013","journal-title":"Food Chem"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0037","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1211\/jpp.59.11.0012","article-title":"(4\u2032,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice","volume":"59","author":"Panda","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110298","article-title":"Apigenin, flavonoid component isolated from Gentiana veitchiorum flower suppresses the oxidative stress through LDLR-LCAT signaling pathway","volume":"128","author":"Dou","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0039","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.biopha.2018.06.108","article-title":"Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway","volume":"105","author":"Yang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","article-title":"Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways","volume":"71","author":"Lv","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0041","first-page":"2965","article-title":"Apigenin reduces the excessive accumulation of lipids induced by palmitic acid via the AMPK signaling pathway in HepG2 cells","volume":"18","author":"Lu","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155072","article-title":"Regulation of main ncRNAs by polyphenols: a novel anticancer therapeutic approach","volume":"120","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/BSR20100065","article-title":"Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer","volume":"31","author":"Mudduluru","year":"2011","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jnutbio.2024.109717_bib0044","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1039\/D1FO00664A","article-title":"Oral administration of EGCG solution equivalent to daily achievable dosages of regular tea drinkers effectively suppresses miR483-3p induced metastasis of hepatocellular carcinoma cells in mice","volume":"12","author":"Kang","year":"2021","journal-title":"Food Funct"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286324001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286324001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:16:56Z","timestamp":1731331016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286324001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":44,"alternative-id":["S0955286324001499"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109717","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic miR-363 promotes nonalcoholic fatty liver disease by suppressing INSIG1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109717"}}